Global Humanized Antibody Market Growth (Status and Outlook) 2023-2029

February 2023 | 89 pages | ID: GB7AF9B5B362EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are replaced by human sequences, and reducing the Its heterogeneity is beneficial to the human body.The constant region part (ie, CH and CL regions) of humanized antibody are encoded by human antibody genes. Human antibodies can greatly reduce the immune side effects of heterologous antibodies on the human body.

LPI (LP Information)' newest research report, the “Humanized Antibody Industry Forecast” looks at past sales and reviews total world Humanized Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Humanized Antibody sales for 2023 through 2029. With Humanized Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Humanized Antibody industry.

This Insight Report provides a comprehensive analysis of the global Humanized Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Humanized Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Humanized Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Humanized Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Humanized Antibody.

The global Humanized Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Humanized Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Humanized Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Humanized Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Humanized Antibody players cover Amgen, MorphoSys, Huston BioConsulting LLC, Seattle Genetics, Zyngenia, Genentech, ImmunoGen, Sandoz International and MRC Laboratory of Molecular Biology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Humanized Antibody market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Chimeric Antibody
• Modified Antibody

Segmentation by application

• Laboratory Research
• Clinical Drugs

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen
• MorphoSys
• Huston BioConsulting LLC
• Seattle Genetics
• Zyngenia
• Genentech
• ImmunoGen
• Sandoz International
• MRC Laboratory of Molecular Biology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Humanized Antibody Market Size 2018-2029
  2.1.2 Humanized Antibody Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Humanized Antibody Segment by Type
  2.2.1 Chimeric Antibody
  2.2.2 Modified Antibody
2.3 Humanized Antibody Market Size by Type
  2.3.1 Humanized Antibody Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Humanized Antibody Market Size Market Share by Type (2018-2023)
2.4 Humanized Antibody Segment by Application
  2.4.1 Laboratory Research
  2.4.2 Clinical Drugs
2.5 Humanized Antibody Market Size by Application
  2.5.1 Humanized Antibody Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Humanized Antibody Market Size Market Share by Application (2018-2023)

3 HUMANIZED ANTIBODY MARKET SIZE BY PLAYER

3.1 Humanized Antibody Market Size Market Share by Players
  3.1.1 Global Humanized Antibody Revenue by Players (2018-2023)
  3.1.2 Global Humanized Antibody Revenue Market Share by Players (2018-2023)
3.2 Global Humanized Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMANIZED ANTIBODY BY REGIONS

4.1 Humanized Antibody Market Size by Regions (2018-2023)
4.2 Americas Humanized Antibody Market Size Growth (2018-2023)
4.3 APAC Humanized Antibody Market Size Growth (2018-2023)
4.4 Europe Humanized Antibody Market Size Growth (2018-2023)
4.5 Middle East & Africa Humanized Antibody Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Humanized Antibody Market Size by Country (2018-2023)
5.2 Americas Humanized Antibody Market Size by Type (2018-2023)
5.3 Americas Humanized Antibody Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Humanized Antibody Market Size by Region (2018-2023)
6.2 APAC Humanized Antibody Market Size by Type (2018-2023)
6.3 APAC Humanized Antibody Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Humanized Antibody by Country (2018-2023)
7.2 Europe Humanized Antibody Market Size by Type (2018-2023)
7.3 Europe Humanized Antibody Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Humanized Antibody by Region (2018-2023)
8.2 Middle East & Africa Humanized Antibody Market Size by Type (2018-2023)
8.3 Middle East & Africa Humanized Antibody Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMANIZED ANTIBODY MARKET FORECAST

10.1 Global Humanized Antibody Forecast by Regions (2024-2029)
  10.1.1 Global Humanized Antibody Forecast by Regions (2024-2029)
  10.1.2 Americas Humanized Antibody Forecast
  10.1.3 APAC Humanized Antibody Forecast
  10.1.4 Europe Humanized Antibody Forecast
  10.1.5 Middle East & Africa Humanized Antibody Forecast
10.2 Americas Humanized Antibody Forecast by Country (2024-2029)
  10.2.1 United States Humanized Antibody Market Forecast
  10.2.2 Canada Humanized Antibody Market Forecast
  10.2.3 Mexico Humanized Antibody Market Forecast
  10.2.4 Brazil Humanized Antibody Market Forecast
10.3 APAC Humanized Antibody Forecast by Region (2024-2029)
  10.3.1 China Humanized Antibody Market Forecast
  10.3.2 Japan Humanized Antibody Market Forecast
  10.3.3 Korea Humanized Antibody Market Forecast
  10.3.4 Southeast Asia Humanized Antibody Market Forecast
  10.3.5 India Humanized Antibody Market Forecast
  10.3.6 Australia Humanized Antibody Market Forecast
10.4 Europe Humanized Antibody Forecast by Country (2024-2029)
  10.4.1 Germany Humanized Antibody Market Forecast
  10.4.2 France Humanized Antibody Market Forecast
  10.4.3 UK Humanized Antibody Market Forecast
  10.4.4 Italy Humanized Antibody Market Forecast
  10.4.5 Russia Humanized Antibody Market Forecast
10.5 Middle East & Africa Humanized Antibody Forecast by Region (2024-2029)
  10.5.1 Egypt Humanized Antibody Market Forecast
  10.5.2 South Africa Humanized Antibody Market Forecast
  10.5.3 Israel Humanized Antibody Market Forecast
  10.5.4 Turkey Humanized Antibody Market Forecast
  10.5.5 GCC Countries Humanized Antibody Market Forecast
10.6 Global Humanized Antibody Forecast by Type (2024-2029)
10.7 Global Humanized Antibody Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Amgen Company Information
  11.1.2 Amgen Humanized Antibody Product Offered
  11.1.3 Amgen Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Amgen Main Business Overview
  11.1.5 Amgen Latest Developments
11.2 MorphoSys
  11.2.1 MorphoSys Company Information
  11.2.2 MorphoSys Humanized Antibody Product Offered
  11.2.3 MorphoSys Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 MorphoSys Main Business Overview
  11.2.5 MorphoSys Latest Developments
11.3 Huston BioConsulting LLC
  11.3.1 Huston BioConsulting LLC Company Information
  11.3.2 Huston BioConsulting LLC Humanized Antibody Product Offered
  11.3.3 Huston BioConsulting LLC Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Huston BioConsulting LLC Main Business Overview
  11.3.5 Huston BioConsulting LLC Latest Developments
11.4 Seattle Genetics
  11.4.1 Seattle Genetics Company Information
  11.4.2 Seattle Genetics Humanized Antibody Product Offered
  11.4.3 Seattle Genetics Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Seattle Genetics Main Business Overview
  11.4.5 Seattle Genetics Latest Developments
11.5 Zyngenia
  11.5.1 Zyngenia Company Information
  11.5.2 Zyngenia Humanized Antibody Product Offered
  11.5.3 Zyngenia Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Zyngenia Main Business Overview
  11.5.5 Zyngenia Latest Developments
11.6 Genentech
  11.6.1 Genentech Company Information
  11.6.2 Genentech Humanized Antibody Product Offered
  11.6.3 Genentech Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Genentech Main Business Overview
  11.6.5 Genentech Latest Developments
11.7 ImmunoGen
  11.7.1 ImmunoGen Company Information
  11.7.2 ImmunoGen Humanized Antibody Product Offered
  11.7.3 ImmunoGen Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 ImmunoGen Main Business Overview
  11.7.5 ImmunoGen Latest Developments
11.8 Sandoz International
  11.8.1 Sandoz International Company Information
  11.8.2 Sandoz International Humanized Antibody Product Offered
  11.8.3 Sandoz International Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Sandoz International Main Business Overview
  11.8.5 Sandoz International Latest Developments
11.9 MRC Laboratory of Molecular Biology
  11.9.1 MRC Laboratory of Molecular Biology Company Information
  11.9.2 MRC Laboratory of Molecular Biology Humanized Antibody Product Offered
  11.9.3 MRC Laboratory of Molecular Biology Humanized Antibody Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 MRC Laboratory of Molecular Biology Main Business Overview
  11.9.5 MRC Laboratory of Molecular Biology Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Humanized Antibody Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Chimeric Antibody
Table 3. Major Players of Modified Antibody
Table 4. Humanized Antibody Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Humanized Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Humanized Antibody Market Size Market Share by Type (2018-2023)
Table 7. Humanized Antibody Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Humanized Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Humanized Antibody Market Size Market Share by Application (2018-2023)
Table 10. Global Humanized Antibody Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Humanized Antibody Revenue Market Share by Player (2018-2023)
Table 12. Humanized Antibody Key Players Head office and Products Offered
Table 13. Humanized Antibody Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Humanized Antibody Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Humanized Antibody Market Size Market Share by Regions (2018-2023)
Table 18. Global Humanized Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Humanized Antibody Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Humanized Antibody Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Humanized Antibody Market Size Market Share by Country (2018-2023)
Table 22. Americas Humanized Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Humanized Antibody Market Size Market Share by Type (2018-2023)
Table 24. Americas Humanized Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Humanized Antibody Market Size Market Share by Application (2018-2023)
Table 26. APAC Humanized Antibody Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Humanized Antibody Market Size Market Share by Region (2018-2023)
Table 28. APAC Humanized Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Humanized Antibody Market Size Market Share by Type (2018-2023)
Table 30. APAC Humanized Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Humanized Antibody Market Size Market Share by Application (2018-2023)
Table 32. Europe Humanized Antibody Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Humanized Antibody Market Size Market Share by Country (2018-2023)
Table 34. Europe Humanized Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Humanized Antibody Market Size Market Share by Type (2018-2023)
Table 36. Europe Humanized Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Humanized Antibody Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Humanized Antibody Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Humanized Antibody Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Humanized Antibody Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Humanized Antibody Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Humanized Antibody Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Humanized Antibody Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Humanized Antibody
Table 45. Key Market Challenges & Risks of Humanized Antibody
Table 46. Key Industry Trends of Humanized Antibody
Table 47. Global Humanized Antibody Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Humanized Antibody Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Humanized Antibody Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Humanized Antibody Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Amgen Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 52. Amgen Humanized Antibody Product Offered
Table 53. Amgen Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Amgen Main Business
Table 55. Amgen Latest Developments
Table 56. MorphoSys Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 57. MorphoSys Humanized Antibody Product Offered
Table 58. MorphoSys Main Business
Table 59. MorphoSys Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. MorphoSys Latest Developments
Table 61. Huston BioConsulting LLC Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 62. Huston BioConsulting LLC Humanized Antibody Product Offered
Table 63. Huston BioConsulting LLC Main Business
Table 64. Huston BioConsulting LLC Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Huston BioConsulting LLC Latest Developments
Table 66. Seattle Genetics Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 67. Seattle Genetics Humanized Antibody Product Offered
Table 68. Seattle Genetics Main Business
Table 69. Seattle Genetics Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Seattle Genetics Latest Developments
Table 71. Zyngenia Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 72. Zyngenia Humanized Antibody Product Offered
Table 73. Zyngenia Main Business
Table 74. Zyngenia Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Zyngenia Latest Developments
Table 76. Genentech Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 77. Genentech Humanized Antibody Product Offered
Table 78. Genentech Main Business
Table 79. Genentech Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Genentech Latest Developments
Table 81. ImmunoGen Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 82. ImmunoGen Humanized Antibody Product Offered
Table 83. ImmunoGen Main Business
Table 84. ImmunoGen Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. ImmunoGen Latest Developments
Table 86. Sandoz International Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 87. Sandoz International Humanized Antibody Product Offered
Table 88. Sandoz International Main Business
Table 89. Sandoz International Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Sandoz International Latest Developments
Table 91. MRC Laboratory of Molecular Biology Details, Company Type, Humanized Antibody Area Served and Its Competitors
Table 92. MRC Laboratory of Molecular Biology Humanized Antibody Product Offered
Table 93. MRC Laboratory of Molecular Biology Main Business
Table 94. MRC Laboratory of Molecular Biology Humanized Antibody Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. MRC Laboratory of Molecular Biology Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Humanized Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Humanized Antibody Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Humanized Antibody Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Humanized Antibody Sales Market Share by Country/Region (2022)
Figure 8. Humanized Antibody Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Humanized Antibody Market Size Market Share by Type in 2022
Figure 10. Humanized Antibody in Laboratory Research
Figure 11. Global Humanized Antibody Market: Laboratory Research (2018-2023) & ($ Millions)
Figure 12. Humanized Antibody in Clinical Drugs
Figure 13. Global Humanized Antibody Market: Clinical Drugs (2018-2023) & ($ Millions)
Figure 14. Global Humanized Antibody Market Size Market Share by Application in 2022
Figure 15. Global Humanized Antibody Revenue Market Share by Player in 2022
Figure 16. Global Humanized Antibody Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Humanized Antibody Market Size 2018-2023 ($ Millions)
Figure 18. APAC Humanized Antibody Market Size 2018-2023 ($ Millions)
Figure 19. Europe Humanized Antibody Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Humanized Antibody Market Size 2018-2023 ($ Millions)
Figure 21. Americas Humanized Antibody Value Market Share by Country in 2022
Figure 22. United States Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Humanized Antibody Market Size Market Share by Region in 2022
Figure 27. APAC Humanized Antibody Market Size Market Share by Type in 2022
Figure 28. APAC Humanized Antibody Market Size Market Share by Application in 2022
Figure 29. China Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Humanized Antibody Market Size Market Share by Country in 2022
Figure 36. Europe Humanized Antibody Market Size Market Share by Type (2018-2023)
Figure 37. Europe Humanized Antibody Market Size Market Share by Application (2018-2023)
Figure 38. Germany Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Humanized Antibody Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Humanized Antibody Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Humanized Antibody Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Humanized Antibody Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 52. APAC Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 53. Europe Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 55. United States Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 56. Canada Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 59. China Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 60. Japan Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 61. Korea Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 63. India Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 64. Australia Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 65. Germany Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 66. France Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 67. UK Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 68. Italy Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 69. Russia Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 70. Spain Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 73. Israel Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Humanized Antibody Market Size 2024-2029 ($ Millions)
Figure 76. Global Humanized Antibody Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Humanized Antibody Market Size Market Share Forecast by Application (2024-2029)